GreenPeptide Co., Ltd. reported consolidated earnings results for the third quarter ended December 31, 2016. For the period, the company reported net sales of JPY 431 million. Operating loss was JPY 699 million. Ordinary loss was JPY 711 million. Loss attributable to owners of parent was JPY 712 million or loss of JPY 21.45 per share.

For the year ending March 31, 2017, the company expects net sales of JPY 406 million, operating loss of JPY 1,306 million, ordinary loss of JPY 1,306 million and net loss of JPY 1,308 million or loss attributable to owners of parents of JPY 41.14 per share.